Accutane IBD Attorney

Submit your Accutane case for a Free Case Evaluation or call 314-662-2836, and one of our experienced attorneys from a national law firm will evaluate your case.  We are presently investigating and filing our Accutane cases.

On June 26, 2009 Roche Holding AG, the manufacturer of Accutane, recalled their popular cancer and acne medication Accutane after stating that that they have awarded over $33 million in lawsuits directly related to bowel disease claims.

Accutane recent news:

Roche Ordered to Pay $25 Million to Accutane User

Accutane Injury Results in $10.5 Million Judgment

Accutane Side Effects

Our national firm is currently accepting the following types of Accutane injury cases:

- Inflammatory Bowel Disease (IBD)
- Premature Closure of Growth Plates
- Birth Defects
- Ulcerative Colitis
- Crohn’s Disease

The lawyers and attorneys at our firm are currently offering free evaluations to people suffering from Inflammatory Bowel Disease (IBD) as a result of the drug Accutane.

IBD is an extremely painful and debilitating condition that often requires the removal of the colon. The Accutane injury attorneys at our firm know how devastating a diagnosis of IBD is, and we will work hard to make sure that Hoffman-La Roche, the maker of this defective drug, is held accountable for its serious side effects.Victims of IBD will often need medical care for the rest of their lives, and can face staggering medical bills. Because of the chronic pain and debilitating diarrhea that typically accompanies IBD, many victims are unable to work. Our Accutane injury lawyers will do everything in their power to help victims of this dangerous drug get their lives back on track.

Accutane – known generically as Isotretinoin – is a medication used for the treatment of severe acne. Accutane helps those who have acne by decreasing the amount of oil produced by the sebaceous glands and increasing the skin renewal rate. It is a retinoid, meaning it derives from vitamin A and is found in small quantities naturally in the body. Vitamin A in large quantities is known to be toxic to the body.

Accutane is normally reserved for patients whose acne has not responded to other forms of treatment, such as antibiotics.

Accutane is meant for only the most severe forms of acne, but sometimes, doctors do prescribe it to treat more moderate forms of the condition. This is unfortunate, because Accutane is known to carry serious side effects.

Approved by the Food & Drug Administration (FDA) in 1982, Accutane has been the subject of controversy for years. In addition to IBD, the drug has been associated with many other problems. It first garnered attention in the late eighties for causing severe birth defects. It has also been known to cause psychiatric problems, and has been linked to hundreds of suicides in the United States.

The researchers of the study found that out of 85 cases reported between 1997 and 2002 to the FDA, 62 cases were deemed “highly probable” or “probable” for Accutane as the cause of IBD. These injuries include ulcerative colitis and Crohn’s disease, which require life-long therapy, often necessitating surgical intervention.

Yaz Birth Control Side Effects are linked to Stroke, Blood
Clots, Heart Attacks, gall bladder injury and other life-threatening side effects

Submit your Yaz/Yasmin case for a Free Case Evaluation or call 314-662-2836, and one of our experienced attorneys from a national law firm will evaluate your case.

We will file your Yaz/Yasmin case individually, not as part of a class action: We represent each women suffering from Yaz on 100% contingency basis which means that there are never any legal fees until we settle your case. We will file your case individually, not as a class action.

Yaz/Yasmin Information

The use of the birth control Yaz/Yasmin has been associated with serious side effects, which include pulmonary embolism, stroke, deep vein thrombosis (DVT), heart attack, and even death.

Since 2004, at least 50 deaths have been reported in women taking Yasmin and similar contraceptives. Some of these women were as young as 17.

A key ingredient in these drugs can raise blood potassium levels and cause:
Heart attack
Stroke
Gallbladder disease
Kidney disease
Pulmonary embolism
Deep vein thrombosis
Venous Thromboembolism (VTE)
Liver tumors
Death

Yasmin and Yaz are birth control pills manufactured by Bayer Healthcare. The generic brand Ocella is marketed and distributed by Barr Laboratories, Inc. They are combination oral contraceptives [COCs], meaning that like most birth control pills, they contain an estrogenic component and a progestational component. These steroidal components work together in COCs to suppress ovulation, fertilization and implantation and thus prevent pregnancy.

Yasmin and Yaz: Birth Control Pills with a “Fourth Generation” Progestin
While Yasmin and Yaz contain the same estrogenic compound, ethinyl estradiol that has been used in the lower dose Pill, or COCs, for decades, the progestin in Yasmin and Yaz is unique. Yasmin and Yaz both contain drospirenone, a “fourth generation” progestin. No other birth control pills contain drospirenone, except for a recently approved generic version of Yasmin and Yaz, marketed by Teva under the trade name Ocella. In addition, a newly approved hormonal product for menopause called Angeliq contains drospirenone.

Because drospirenone is new, there are not decades of data available to support its safe use as there are with the second generation progestins. Studies which were done before FDA approval, however, indicate that drospirenone has certain effects that are different than those of traditional second generation progestins and potentially more dangerous. Specifically, drospirenone causes an increase in potassium levels in the blood, which can lead to a condition known as hyperkalemia if the potassium levels become too high. Hyperkalemia can cause heart rhythm disturbances, such as extrasystolies, pauses or bradycardia.

If left untreated, hyperkalemia can be fatal. In particular, if hyperkalemia disrupts the normal heart rhythms, the flow of the blood through the heart can be slowed to the point that it permits blood clots to form. Blood clots in the heart can then lead to heart attacks, or break off and travel to the lungs where they can cause pulmonary embolus, or travel to the brain causing stroke.

Yaz/Yasmin links:

According to a new study published in the British Medical Journal, Yaz and Yasmin, carry a higher risk of blood clots compared with others birth control bills. New York Times (9/25/09): “Health Concerns Over Popular Contraceptives.”

“The U.S. Food and Drug Administration is requiring Bayer HealthCare Pharmaceuticals to run ads correcting claims about a popular birth control pill. Federal health officials said previous ads overstated the ability of the birth control pill Yaz to cure acne or reduce premenstrual mood swings and played down potential health risks,” The New York Times reported this year. New York Times (2/9/09): “A Birth Control Pill That Promised Too Much.”

The FDA warning letter regarding Yaz/Yasmin

Reglan Metoclopramide Tardive Dyskinesia Lawsuits

Submit your Reglan case for a Free Case Evaluation or call 314-662-2836, and
one of our experienced attorneys from a national law firm will evaluate your case.  We are presently investigating and filing our Reglan cases.

Metoclopramide is available under various trade names including Maxolon (Shire/Valeant), Reglan (Schwarz Pharma), Degan (Lek), Maxeran (Sanofi Aventis), Primperan (Sanofi Aventis), and Pylomid (Bosnalijek). If you have taken any Metoclopramide, we will evaluate your case.

FDA WARNING POINTS TO DANGERS OF LONG-TERM USE OF REGLAN; TWO MILLION AMERICANS WITH REFLUX DISEASE COULD BE AT RISK

The U.S. Food and Drug Administration has ordered the makers of the acid reflux medication Reglan to include a black box warning .The reason: the drug may lead to a serious condition known as tardive dyskinesia after chronic or high-dosage use.People with tardive dyskinesia experience involuntary, repetitive and purposeless movements.

Symptoms of Tardive Dyskinsesia include:

* Tongue moves in mouth
* Tongue protrudes out of mouth
* Chewing
* Teeth grinding
* Difficulty swallowing (choking)
* Difficulty eating
* Difficulty speaking
* Facial grimacing
* Puckering
* Blinking
* Eyes pull to one side
* Excessively frequent eye movements
* Repeated forehead wrinkling
* Blowing/puffing/burping/unintended noises/clicking
* Difficulty breathing (diaphragm)
* Different (muscle tension or “hatband”) headaches
* Jaw ache/tension/spasm
* Head pulls to one side
* Unusual dental problems
* Biting inside of mouth\tongue
* Drooling
* Slurred speech\thick tongue
* Arms move
*  Legs move (like restless leg syndrome, but not)
* Fingers move
* Hands drawn up
* Hands cramped (difficulty grasping\holding)
* Arms/hands shake
*  Toes move
* Feet cramp
* Difficulty walking
*  Back twisting or arching
* Stomach movements
* Hip gyrating
* Diaphragm uncontrolled causing grunting and unusual noises
* Unusual feeling of rapid heartbeat\anxiety
* Tremulousness
* Bouncy legs

If you or a loved one have taken Reglan (Generic name: Metoclopramide) and been diagnosed with Tardive Dyskinesia (“TD”), you should contact us immediately. You may be entitled to compensation and we can help.Metoclopramide (INN) is an antiemetic and gastroprokinetic agent. Thus it is primarily used to treat nausea and vomiting, and to facilitate gastric emptying in patients with gastroparesis.

The manufacturers of Reglan and its generic metoclopramide mention the link between the development of TD and the drug on its labeling, nevertheless, they suggest the incidence rarely occurs.It is important to understand that the Food & Drug Administration has only approved Reglan for short-term use (4 to 12 weeks) and only when conservative treatment fails.

Safety experts from the Duke University School of Medicine, publishing in the November/December 2004 Journal of the American Pharmacists Association, caution that the use of Reglan is increasing and that this fact may result in more cases of drug-induced movement disorders from the medication.

Reglan links:

FDA Adverse Events Data Reveals at Least 106 Serious Conditions Reported Among Reglan Users

Studies Show Popular Reflux Drug Reglan Dangerous, Ineffective

Information about Tardive Dyskinesia